A bladder preservation strategy comprising atezolizumab and radiation therapy showed promising efficacy and manageable toxicity. This approach offers an alternative option for patients with invasive bladder cancer who are unfit for or refuse radical cystectomy.
A bladder preservation strategy comprising atezolizumab and radiation therapy showed promising efficacy and manageable toxicity. This approach offers an alternative option for patients with invasive bladder cancer who are unfit for or refuse radical cystectomy.